258 related articles for article (PubMed ID: 26234678)
21. Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation.
Li S; Hong X; Wei Z; Xie M; Li W; Liu G; Guo H; Yang J; Wei W; Zhang S
Front Microbiol; 2019; 10():2483. PubMed ID: 31749782
[TBL] [Abstract][Full Text] [Related]
22. E3 ligase UHRF2 stabilizes the acetyltransferase TIP60 and regulates H3K9ac and H3K14ac via RING finger domain.
Zeng S; Wang Y; Zhang T; Bai L; Wang Y; Duan C
Protein Cell; 2017 Mar; 8(3):202-218. PubMed ID: 27743347
[TBL] [Abstract][Full Text] [Related]
23. A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.
Ebner FA; Sailer C; Eichbichler D; Jansen J; Sladewska-Marquardt A; Stengel F; Scheffner M
J Biol Chem; 2020 Oct; 295(44):15070-15082. PubMed ID: 32855237
[TBL] [Abstract][Full Text] [Related]
24. The roles of E6-AP and MDM2 in p53 regulation in human papillomavirus-positive cervical cancer cells.
Traidej M; Chen L; Yu D; Agrawal S; Chen J
Antisense Nucleic Acid Drug Dev; 2000 Feb; 10(1):17-27. PubMed ID: 10726657
[TBL] [Abstract][Full Text] [Related]
25. Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness.
Brimer N; Drews CM; Vande Pol SB
PLoS Pathog; 2017 Dec; 13(12):e1006781. PubMed ID: 29281732
[TBL] [Abstract][Full Text] [Related]
26. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
27. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
28. HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP.
Shai A; Nguyen ML; Wagstaff J; Jiang YH; Lambert PF
Oncogene; 2007 May; 26(23):3321-8. PubMed ID: 17130828
[TBL] [Abstract][Full Text] [Related]
29. Caffeic Acid Phenethyl Ester Inhibits Ubiquitination and Degradation of p53 and Blocks Cervical Cancer Cell Growth.
Li W; Yang C; Shi Z; Long Q; Cheng Z; He S; Dong J; Liu T; Wang C
Curr Mol Med; 2023; 23(9):960-970. PubMed ID: 36043765
[TBL] [Abstract][Full Text] [Related]
30. Orthogonal ubiquitin transfer reveals human papillomavirus E6 downregulates nuclear transport to disarm interferon-γ dependent apoptosis of cervical cancer cells.
Wang Y; Liu R; Liao J; Jiang L; Jeong GH; Zhou L; Polite M; Duong D; Seyfried NT; Wang H; Kiyokawa H; Yin J
FASEB J; 2021 Nov; 35(11):e21986. PubMed ID: 34662469
[TBL] [Abstract][Full Text] [Related]
31. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.
Pim D; Thomas M; Javier R; Gardiol D; Banks L
Oncogene; 2000 Feb; 19(6):719-25. PubMed ID: 10698489
[TBL] [Abstract][Full Text] [Related]
32. Development of screening systems for drugs against human papillomavirus-associated cervical cancer: based on E6-E6AP binding.
Cho Y; Cho C; Joung O; Lee K; Park S; Yoon D
Antiviral Res; 2000 Sep; 47(3):199-206. PubMed ID: 10974372
[TBL] [Abstract][Full Text] [Related]
33. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
34. E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice.
Shai A; Pitot HC; Lambert PF
Cancer Res; 2010 Jun; 70(12):5064-73. PubMed ID: 20530688
[TBL] [Abstract][Full Text] [Related]
35. GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.
Zhou Y; Wei Y; Zhu J; Wang Q; Bao L; Ma Y; Chen Y; Feng D; Zhang A; Sun J; Nallar SC; Shen K; Kalvakolanu DV; Xiao W; Ling B
PLoS One; 2011; 6(7):e22065. PubMed ID: 21765936
[TBL] [Abstract][Full Text] [Related]
36. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
37. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
38. Identification of MicroRNAs That Stabilize p53 in Human Papillomavirus-Positive Cancer Cells.
Martínez-Noël G; Szajner P; Kramer RE; Boyland KA; Sheikh A; Smith JA; Howley PM
J Virol; 2022 Feb; 96(4):e0186521. PubMed ID: 34878887
[TBL] [Abstract][Full Text] [Related]
39. Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.
Masuda Y; Saeki Y; Arai N; Kawai H; Kukimoto I; Tanaka K; Masutani C
J Biol Chem; 2019 Oct; 294(41):14860-14875. PubMed ID: 31492752
[TBL] [Abstract][Full Text] [Related]
40. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
